Evidence map›Paper›PMID 22275845›Full record

ReviewDialogues in clinical neuroscience2011

A lifespan view of anxiety disorders.

Eric J Lenze, Julie Loebach Wetherell

Abstract readReview
In one paragraph

Review in Dialogues in clinical neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Eric J LenzeDepartment of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, USA. lenzee@wustl.edu
Julie Loebach Wetherell

Funding

2/3-Incomplete Response in Late-Life Depression: Getting to RemissionR01MH083648 · NIMH · WASHINGTON UNIVERSITY · PI LENZE, ERIC J · 2009 to 2013
$2.0M
Exposure Therapy for Fear of Falling in Older AdultsR34MH086668 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WETHERELL, JULIE L · 2010 to 2012
$691k
CBT Augmentation of SSRI Treatment for Geriatric GADR34MH080151 · NIMH · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI WETHERELL, JULIE L · 2007 to 2009
$552k
NIMH NIH HHS R01 MH083648NIMH NIH HHS R34 MH080151NIMH NIH HHS R34 MH086668
6 · The paper itself

Abstract

Neurodevelopmental changes over the lifespan, from childhood through adulthood into old age, have important implications for the onset, presentation, course, and treatment of anxiety disorders. This article presents data on anxiety disorders as they appear in older adults, as compared with earlier in life. In this article, we focus on aging-related changes in the epidemiology, presentation, and treatment of anxiety disorders. Also, this article describes some of the gaps and limitations in our understanding and suggests research directions that may elucidate the mechanisms of anxiety disorder development later in life. Finally we describe optimal management of anxiety disorders across the lifespan, in "eight simple steps" for practitioners.

Indexed as

Anxiety DisordersAgedAgingAnti-Anxiety AgentsHumansPrevalencePsychotherapyAnti-Anxiety Agentsantidepressantanxietycortisoldiagnosiselderlyneuropsychologypsychotherapy

Identifiers

PMID22275845
PMCPMC3263387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.